Abstract: An apparatus, system and method for providing an optical filter for an intraocular lens. The apparatus, system and method may include at least one optical filtering layer applied to at least one surface of the optic, wherein the optical filtering layer may at least partially filter light through the intraocular lens. The at least one optical filtering layer may include different types of optical filters including a neutral density filter, a chromatic filter, a photochromatic filter, and a polarizing filter. These filters may be used to reduce the transmission of light through the intraocular lens.

Abstract: An apparatus, system and method for providing an optical filter for an intraocular lens. The apparatus, system and method may include at least one optical filtering layer applied to at least one surface of the optic, wherein the optical filtering layer may at least partially filter light through the intraocular lens. The at least one optical filtering layer may include different types of optical filters including a neutral density filter, a chromatic filter, a photochromatic filter, and a polarizing filter. These filters may be used to reduce the transmission of light through the intraocular lens.

Abstract: Disclosed are substantially clear nutritional liquids comprising protein and calcium HMB wherein soluble protein represents from about 65% to 100% by weight of total protein. The liquids have a pH of from about 2.8 to about 4.6 and may be manufactured as a hot fill product. The substantially clear nutritional liquids may also have a weight ratio of calcium HMB to soluble calcium of from 4.5:1 to 7.3:1. In some embodiments, the substantially clear nutritional liquids are substantially free of fat, and may optionally include isomaltulose and/or beta alanine.

Abstract: An apparatus, system and method for providing an optical filter for an intraocular lens. The apparatus, system and method may include at least one optical filtering layer applied to at least one surface of the optic, wherein the optical filtering layer may at least partially filter light through the intraocular lens. The at least one optical filtering layer may include different types of optical filters including a neutral density filter, a chromatic filter, a photochromatic filter, and a polarizing filter. These filters may be used to reduce the transmission of light through the intraocular lens.

Abstract: Disclosed are concentrated, liquid, human milk fortifier compositions comprising from protein, carbohydrate and fat. The concentrated compositions are formulated for addition to human milk and are especially useful for providing nutrition to preterm infants in neonatal intensive care units or similar other institutional settings.

Abstract: A closure for a container is described. The container has an opening through which contents of the container are dispensed and a holding member (255, 285, 295, 305, 315, 316, 317, 340, 350) for cooperating with the closure to retain the closure on the container. A sealing member (220) is configured to sealingly close the container opening. The sealing member includes a retention member (260, 275, 290, 300, 310, 325, 335, 345, 355) engageable with the holding member of the container to retain the sealing member in sealing engagement with the container. A cap member (225) has a top rim and a sidewall depending from the top rim. The sidewall includes an attachment member (160) for attachment to the container and an engagement member (245) that operatively couples the sealing member to the cap member upon placement of the cap member on the container. The cap member is rotatable relative to the container and relative to the sealing member.

Abstract: Disclosed are compositions and corresponding methods for treating fibrocystic breast disease or other breast-related disease or condition. The compositions comprise, per serving or dose, from zero to about 400 ?g selenium, from about 100 mg to about 6000 mg gamma linolenic acid, and about 0.15 mg to about 5 mg iodine, with nutritional embodiments further comprising one or more of protein, fat, carbohydrate, vitamins, and minerals and providing from about 50 to about 1000 kcal of energy per severing or dose. Also disclosed are in-vitro studies showing that certain combinations of gamma linolenic acid, iodine, and/or selenium may 1) inhibit breast cancer or fibrocystic cell proliferation, 2) reinforce the function of tight junctions of endothelial cells and of mammary epithelial cells in estrogen-sensitive conditions, and 3) reduce the risk of vascular invasion by breast cancer cells.

Abstract: A single-use pouch (10) for liquid product has a front panel (12) and a back panel (14). The front and back panels at least in part cooperatively define an interior space (15) of the pouch. The interior space has a total liquid capacity. A volume of liquid product is contained within the interior space. The volume of liquid product is less than about 60% of the total liquid capacity of the pouch.

Abstract: Disclosed are compositions, including low-calorie beverages or liquids, comprising isoleucine, leucine, valine, cysteine, and methionine, in specified amounts, weight ratios, or both. The compositions are especially useful in treating individuals afflicted with impaired glucose tolerance or diabetes.

Abstract: Disclosed are methods of manufacturing powdered nutritional products, including powdered infant formulas and powdered adult nutritional products, using extrusion. The methods include utilizing ultrasonic energy in the extruder during manufacturing. The application of ultrasonic energy to the extruder allows the fat globules present in raw materials to be effectively emulsified by hydrated protein present in the feed stream such that the resulting powdered extruded product has a low free fat level, is less susceptible to oxidation and rancidity, and can be reconstituted without substantial fat separation.

Abstract: Disclosed are compositions, including low-calorie beverages or liquids, comprising isoleucine, leucine, valine, cysteine, and methionine, in specified amounts, weight ratios, or both. The compositions are especially useful in treating individuals afflicted with impaired glucose tolerance or diabetes.

Abstract: Disclosed are nutritional compositions and methods for preparing the compositions, comprising fat, protein, and carbohydrate, including a combination of curcumin, demethoxycurcumin, and bisdemethoxycurcumin, which combination is solubilized in a polar oil having an HLB value of from about 0.7 to about 14 wherein the weight ratio of the bisdemethoxycurcumin to the curcumin is from about 1:1 to about 1:7 and the weight ratio of the bisdemethoxycurcumin to the demethoxycurcumin is from about 1:1 to about 1:2.5. The composition provides a selected ratio of curcuminoids having improved biological activity, bioavailability, and reduced color impact.

Abstract: Disclosed are compositions, including low-calorie beverages or liquids, comprising isoleucine, leucine, valine, cysteine, and methionine, in specified amounts, weight ratios, or both. The compositions are especially useful in treating individuals afflicted with impaired glucose tolerance or diabetes.

Abstract: Disclosed are packaged compositions comprising an aseptically sterilized container and a sterilized, concentrated, nutritional liquid emulsion that is aseptically packaged and sealed within the container. Also disclosed are methods for making and using the packaged compositions. In some embodiments, the aseptically packaged, concentrated, nutritional liquid emulsions have a desirable flavor and aroma and have increased emulsion stability.

Abstract: Disclosed are substantially clear nutritional liquids comprising protein and calcium HMB wherein soluble protein represents from about 65% to 100% by weight of total protein. The liquids have a pH of from about 2.8 to about 4.6 and may be manufactured as a hot fill product. The substantially clear nutritional liquids may also have a weight ratio of calcium HMB to soluble calcium of from 4.5:1 to 7.3:1. In some embodiments, the substantially clear nutritional liquids are substantially free of fat, and may optionally include isomaltulose and/or beta alanine.

Abstract: The present invention provides a food product comprising: a formed reduced glycemic response cereal component; and a non-sticky reduced glycemic response sweetener coating over the formed cereal component, the sweetener coating comprising: a first sticky layer comprising at least about 30% fructose (of the total sweetener coating); a second less sticky layer having a DE value of about 60 or less and comprising up to about 17% fructose and at least about 1% non-fructose carbohydrates (of the total sweetener coating); and third layer comprising crystalline fructose. The present invention also provides a process for forming the sweetener coating over the formed cereal component comprising the following steps: (a) providing a formed cereal component having thereon a first sticky layer comprising fructose; (b) forming over the first sticky layer a less stick second layer comprising non-fructose carbohydrates and optionally fructose; and (c) applying crystalline fructose over the second layer.

Abstract: A bottle packaging includes a groove on the neck of a bottle with the groove spaced longitudinally from a shoulder of the bottle a distance greater than or equal to a width of the groove, and upper and lower portions of the neck may have outer transverse cross-sectional dimensions that are substantially equal to one another. An upper circumferential sidewall of the groove may be chamfered, while a lower circumferential sidewall may be concave. The bottle may be combined with an adapter such that when the adapter is releasably connected to the bottle, a lowermost rim of the adapter is spaced longitudinally from an upper reach of the groove. The adapter may include a detent on an inner surface thereof adapted to removably seat in the groove to releasably connect the adapter to the bottle. A closure member may include at least one of a detent and a sealing member removably seated in the groove.

Abstract: Disclosed are compositions, including low-calorie beverages or liquids, comprising isoleucine, leucine, valine, cysteine, and methionine, in specified amounts, weight ratios, or both. The compositions are especially useful in treating individuals afflicted with impaired glucose tolerance or diabetes.

Abstract: Disclosed are compositions, including low-calorie beverages or liquids, comprising isoleucine, leucine, valine, cysteine, and methionine, in specified amounts, weight ratios, or both. The compositions are especially useful in treating individuals afflicted with impaired glucose tolerance or diabetes.